Response to systemic therapies in granulomatous cheilitis: Retrospective multicenter series of 61 patients.

Competing Interests: Conflicts of interest Dr Girard declares conflicts of interest with AbbVie, Janssen, Lilly, Novartis, Amgen, and UCB. Dr Misery declares conflicts of interest with AbbVie (lecture, clinical trial, advisory board), Amgen (lecture, clinical trial), Celgene (grant, consultant), Janssen (lecture, clinical trial, advisory board), Pfizer (clinical trial, advisory board), and Sanofi (clinical trial, advisory board). Stephane Nahon declares lectures or advisory board fees from AbbVie, MSD, Vifor Pharma, Pfizer, Janssen, and Ferring. Dr Sibaud declares fees and honoraries from Novartis, Bristol Myers Squibb, Bayer, Incyte, Pierre Fabre, Sanofi, and Bayer. Dr Samimi has received fees from Bristol Myers Squibb for speaking at an educational meeting for residents and has received reimbursement for travel and accommodation expenses from Bristol Myers Squibb, Janssen, AbbVie, and MSD. Authors Frédéric Jaouen and Fricain and Drs Tessier, Vaillant, Azib-Meftah, Bénéton, Delaporte, Kaddour, Ingen-Housz-Oro, Masson-Regnault, and Bessis have no conflicts of interest to declare.